Overall, 17.7 cases of myocarditis reported per million vaccinations; 77 percent had symptom resolution at time of report
Rate of Self-Poisoning Increased During Pandemic for 10- to 19-Year-Olds
Increases in rates of 73.0, 48.8, and 36.8 percent seen for children aged 10 to 12 years, 13 to 15 years, and girls
Discrimination in Health Care Linked to Nonvaccination Against COVID-19
Reported experiences of racial and ethnic discrimination linked to difference in prevalence of nonvaccination
Dexamethasone Still Beneficial for Some Inpatients With COVID-19
Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
COVID-19 Vaccines Effective Against Moderate, Severe Disease in Children, Teens
Vaccine effectiveness waned significantly after ≥150 days during the omicron variant phase
Amubarvimab Plus Romlusevimab Safe, Effective for COVID-19
Reduces risk for hospitalizations and/or deaths for nonhospitalized patients at high risk for clinical progression
Intentional, Suspected Suicidal Cannabis Exposures Increased From 2009 to 2021
However, most cases involved more than one substance
COVID-19 mRNA Booster Authorizations Expanded
The U.S. Food and Drug Administration (FDA) today announced it amended the emergency use authorizations of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.
This action on April 18, 2023, includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) for all doses administered to individuals six months of age and older, including for an additional dose or doses for specific populations.
SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
Fraction of incident diabetes cases attributable to SARS-CoV-2 infection was 3.41 percent overall, 4.75 percent among men
Oral Fluvoxamine Plus Budesonide Cuts Severe Disease in COVID-19
Reduction in incidence of severe disease requiring advanced care seen among high-risk outpatients with COVID-19